Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large patient cohorts.#We prospectively analyzed ICD-related complications in 440 consecutive patients who underwent first ...
A total of 37 patients with a VAD in whom an ICD has been implanted, explanted or replaced, were retrospectively analyzed. Results All ICD related procedures were successfully performed. There were no procedure-related deaths. Perioperative anticoagulation was achieved with intravenous heparin, which ...
There are limited data available that follow the post-procedural outcomes of patients with cardiac sarcoidosis (CS) who have had an ICD implanted. Areas Covered: This review highlights studies that focused on both appropriate and inappropriate therapies in those with an ICD, as well as device ...
procedure76.9Thrombosis (venous/lead)21.9Haematoma54.9Chronic abdominal cavity post-explant10.9Conclusions There is a significant rate of ICD lead failure in patients with ICCs, which may be expected given the high frequency of Sprint Fidelis leads implanted during this period and the long follow-up....
This study aims to describe the incidence and nature of device-related complications in young transvenous ICD (TV-ICD) and SICD patients.#Single-chamber TV-ICD and SICD patients up to and including the age of 25years implanted between 2002 and 2015 were retrospectively analysed. Complications ...
Introduction: Those with cardiac sarcoidosis (CS) are at risk of sudden cardiac death (SCD), which may be prevented using an implantable cardioverter–defibrillator (ICD). There are limited data available that follow the post-procedural outcomes of patie
In approximately 25% of the cases in which ICDs were implanted, various degrees of venous stenosis were reported [19]. Patients who present thromboembolic events attributable to a lead fragment or thrombus on a lead or that cannot be treated by other methods, or those who associate superior ven...
The last several years have been characterized by a shift in device indication and type, with 81.1% of patients now implanted as destination therapy and 92.7% receiving an LVAD with full magnetic levitation in 2021 [20]. Table 4. Terms describing various indications for mechanical circulatory ...